Sporadic infection with Shiga toxin-producing Escherichia coli (STEC) in New Mexico increased from 0.9 cases per 100,000 population (95% confidence interval [CI] 0.5-1.36) in 2004 to 1.7 (95% CI 1.14-2.26) in 2007. Non-O157 STEC was more common in nonwhite residents, children <5 years of age, and urban residents.
The Study
All STEC isolates or broths were sent for confirmation to the Scientific Laboratory Division of the New Mexico Department of Health, where Shiga toxin expression was confirmed by enzyme immunoassay (EIA); the broth was then cultured and preliminarily serotyped. Pulsed-field gel electrophoresis was performed on all isolates. The laboratory submitted non-O157 STEC isolates to CDC for additional serotyping and PCR testing for toxin genes.
This analysis comprised only sporadic cases of STEC. Negative binomial regression models were used to calculate incidence rates and assess differences in risks for STEC O157 and non-O157 infections. Variables were reporting year, patient age, race/ethnicity, sex, and rural versus urban residence (8) Although STEC O157 was the 1 serotype most often identified, infections caused by non-O157 STEC (all serotypes) were diagnosed more frequently. STEC O26 (18%) and O111 (13%) were the most commonly identified non-O157 STEC serotypes. Other STEC O serotypes (O103, O121, O46, O177, and O91) were responsible for 33% of all STEC infections. Most isolates were positive for toxin gene stx 1 (86%), intimin (66%), and enterohemolysin A (81%).
STEC O157 infection was significantly more likely to be diagnosed in adults (half of all cases, one third of non-O157 STEC cases) than in children (<18 years of age) (p = 0.01). Non-O157 STEC serotypes were most commonly identified in children 1-4 years of age. STEC O157 infections occurred most commonly in children 5-10 years of age, followed by adults >60 years. Sex distributions were similar for patients with STEC O157 and non-O157 infections (55% female vs. 45% male and 52% vs. 48%, respectively). White non-Hispanics, which constitute 43% of New Mexico's population, made up 31% of all confirmed STEC infections in New Mexico; white Hispanics (42%) made up 21% of confirmed STEC cases; and Native Americans (10%) made up 12% of cases (Table 1) .
More laboratory-confirmed STEC infections were diagnosed during the summer months than during the rest of the year. STEC O157 cases were diagnosed more frequently in September (10 cases); non-O157 STEC cases were most frequently diagnosed in June and July (9 cases each).
Although STEC O157 infections was diagnosed in more persons than were non-O157 STEC infections (28% vs. 16%), the difference was not significant. Patients with STEC O157 infections stayed in the hospital a mean of 6 days (median 4), compared with a mean of 4.5 days (median 3) for patients with non-O157 STEC infections, also not significant. All 5 reported cases of HUS were caused by STEC O157.
International travel was related to STEC infection for 12 (11%) patients. Two (5%) STEC O157 cases were travel related, as were 4 (10%) cases each of STEC O111 and O26; and 1 (1%) case each of STEC O128 and O103. Travel to Mexico was documented for 10 of the 12 travelassociated cases.
Most (99 [89%]) persons with STEC were from New Mexico's urban counties. We calculated incidence rate ratios between STEC O157 and non-O157 infections during [2004] [2005] [2006] [2007] (Table 2) , while adjusting for variables that were significant in negative binomial models, including race (white non-Hispanic vs. nonwhite), age (<5 years vs. >5 years), and county (urban vs. rural). More patients with non-O157 STEC infection during this time were nonwhite, <5 years of age, and residents of urban counties. Patients infected with STEC O157 were more likely to be white non-Hispanic, >5 years of age, and residents of rural counties.
Conclusions
The Non-O157 STEC infections ranged from 52% to 74% of all Shiga toxin-positive cases diagnosed each year and 64% of all identified STEC cases. New Mexico was second only to Colorado (2.12 cases per 100,000 population) among FoodNet sites for non-O157 STEC incidence in 2007 (10) . Similar to serotypes reported from other locations, STEC serotypes O26, O111, and O103 made up most non-O157 infections in New Mexico (1), especially O26 and O111 (18% and 13% of all cases, respectively). As previously reported (1), non-O157 STEC infections occurred commonly in young children in this study. They also occurred at a higher rate for non-white New Mexico residents. Another recent study similarly found higher shigellosis rates in counties with higher proportions of Hispanics (11) . This study concurs with others that have reported finding the highest rates of STEC O157 rates in rural communities (with increased opportunities for animal contact) and in the West (12, 13) .
Year-to-year increases in numbers of non-O157 STEC infections, both nationally and in New Mexico, must be interpreted with caution because of changes in laboratory testing practices. Although the state's largest clinical laboratory performed EIAs before active surveillance was implemented in 2004, other laboratories throughout the state might have changed their testing practices.
Risk factors for non-O157 STEC infections may be similar to those for STEC O157 infections (9), but additional studies are needed to elucidate differences and similarities between them, as well as among non-O157 STEC serotypes (14) . Clinical laboratories should simultaneously screen for Shiga toxin and culture all positive isolates to determine the true incidence of non-O157 STEC infections.
